Mounjaro

Diabetes obesity weight loss
Biotech

Lilly triple-G bet sees 16.8% weight loss in ph. 3 diabetes test

Eli Lilly is rounding out its pitch for retatrutide with new data looking at blood sugar reductions and weight loss in patients with Type 2 diabetes.
Fraiser Kansteiner Mar 19, 2026 6:45am
obesity overweight weight loss weigh

Novo's CagriSema loses phase 3 obesity battle against Zepbound

Feb 23, 2026 7:20am
pipelines in the sun

Lilly's next focus: Testing incretins in neuro, immunology fields

Feb 6, 2025 2:35pm
baseball field pitch inning

The most valuable R&D projects? You guessed it: obesity

Jul 11, 2024 5:00am
weight loss scale

UPDATE: Amgen axes an obesity asset, zooms in on MariTide

May 2, 2024 6:16pm
LSX partnering panel

Lilly uses Mounjaro millions to hunt for biotech partners

May 1, 2024 9:26am